ArticleBMC gastroenterology2025
Correlation study of fatty pancreas and fatty liver CT manifestations with biochemical parameters in middle-aged and young adult cholecystectomy patients.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundTo investigate the correlation between the occurrence of pancreatic steatosis, hepatic steatosis, and cholecystectomy, as well as the associated biochemical parameters.
methodsA retrospective analysis was conducted on 409 patients who underwent abdominal CT scans between November 2022 and March 2024. Among them, 127 patients had undergone cholecystectomy (experimental group), while 282 had not (control group). The incidence rates of pancreatic steatosis and hepatic steatosis were compared between the two groups, along with relevant biochemical parameters including total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and fasting blood glucose levels.
resultsThe incidence of pancreatic steatosis in the experimental group was 67.8%, and the incidence of hepatic steatosis was 22%. In the control group, the incidence rates were 54.3% for pancreatic steatosis and 15.6% for hepatic steatosis. The rates of both pancreatic and hepatic steatosis significantly increased following cholecystectomy, with pancreatic steatosis showing a notably higher incidence than hepatic steatosis. Statistical analysis revealed a significant correlation between cholecystectomy and pancreatic steatosis (p < 0.05), whereas no significant correlation was found with hepatic steatosis.
conclusionThe incidence rates of both pancreatic and hepatic steatosis are elevated following cholecystectomy, particularly for pancreatic steatosis. The study indicates a significant association between cholecystectomy and pancreatic steatosis. Therefore, it is recommended to closely monitor patients who have undergone cholecystectomy for the development of pancreatic steatosis, allowing for early diagnosis and intervention to prevent the progression of related conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.